Lupin announced the launch of Zolpidem Sublingual Tablets, the generic version of Purdue‘s Intermezzo.
Intermezzo is an imidazopyridine hypnotic indicated for use as needed for the treatment of insomnia when a middle-of-the-night awakening is followed by difficulty returning to sleep. It interacts with a GABA-BZ complex and shares some of the pharmacological properties of the benzodiazepines. In contrast to the benzodiazepines, which non-selectively bind to and activate all BZ receptor subtypes, zolpidem in vitro binds the BZ1 receptor preferentially with a high affinity ratio of the alpha1/alpha5 subunits.
Zolpidem Sublingual Tablets are available in 1.75mg and 3.5mg strengths.
For more information call (800) 399-2561 or visit Lupin.com.
